{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-006821","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.227455+00:00","generated_at":"2026-06-06T01:20:19.453049+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vivos Therapeutics raises ~$4.0M via warrant exercise; issues new inducement warrants","bullets":["Holder exercises Series B warrant for cash at $4.02/share, yielding ~$4.0M gross proceeds.","Company issues 5-year Series B-1 and 18-month Series B-2 warrants for 735,296 shares each at $5.05.","Inducement transaction expected to close by Feb 20, 2024; proceeds for working capital.","A.G.P./Alliance Global Partners receives 7% cash fee ($280K) plus up to $30K legal expenses.","Company must file resale registration for new warrant shares by Apr 5, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-006821","json":"https://secwatch.observer/filing/0001493152-24-006821.json","markdown":"https://secwatch.observer/filing/0001493152-24-006821.md","text":"https://secwatch.observer/filing/0001493152-24-006821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/0001493152-24-006821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:20:19.453049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}